| Joel R Rygh, CRNA | |
|
4315 Diplomacy Dr, Anchorage, AK 99508-5926 | |
| (907) 729-2300 | |
| (907) 729-2339 |
| Full Name | Joel R Rygh |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 28 Years |
| Location | 4315 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467477802 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 186 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Frontier Anesthesia, Llc | 2567624257 | 11 |
News Archive
Nursing students need a broader understanding of how social conditions influence the health of people living in poverty if they are to provide sensitive care, and more importantly, work toward community and policy solutions to poverty, says a new study done in part by the University of Alberta.
A series of previous studies suggested that the neuronal differentiation rate of bone marrow mesenchymal stem cells during the in vitro culture reached 78-92%, but their in vivo transplantation efficiency, and survival and differentiation rates were very low.
Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nucleotide polymorphisms. The goal is to better predict a prostate cancer's aggressiveness to avoid unnecessary radical treatment.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the release of updated financial information.
Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study from Rafael Meza from the University of Michigan and colleagues and published in the Journal of Thoracic Oncology, a publication of the International Association for the Study of Lung Cancer.
› Verified 6 days ago
| Entity Name | Chugach Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093712358 PECOS PAC ID: 2961465653 Enrollment ID: O20041109001035 |
News Archive
Nursing students need a broader understanding of how social conditions influence the health of people living in poverty if they are to provide sensitive care, and more importantly, work toward community and policy solutions to poverty, says a new study done in part by the University of Alberta.
A series of previous studies suggested that the neuronal differentiation rate of bone marrow mesenchymal stem cells during the in vitro culture reached 78-92%, but their in vivo transplantation efficiency, and survival and differentiation rates were very low.
Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nucleotide polymorphisms. The goal is to better predict a prostate cancer's aggressiveness to avoid unnecessary radical treatment.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the release of updated financial information.
Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study from Rafael Meza from the University of Michigan and colleagues and published in the Journal of Thoracic Oncology, a publication of the International Association for the Study of Lung Cancer.
› Verified 6 days ago
| Entity Name | New Frontier Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255604948 PECOS PAC ID: 2567624257 Enrollment ID: O20120425000361 |
News Archive
Nursing students need a broader understanding of how social conditions influence the health of people living in poverty if they are to provide sensitive care, and more importantly, work toward community and policy solutions to poverty, says a new study done in part by the University of Alberta.
A series of previous studies suggested that the neuronal differentiation rate of bone marrow mesenchymal stem cells during the in vitro culture reached 78-92%, but their in vivo transplantation efficiency, and survival and differentiation rates were very low.
Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nucleotide polymorphisms. The goal is to better predict a prostate cancer's aggressiveness to avoid unnecessary radical treatment.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the release of updated financial information.
Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study from Rafael Meza from the University of Michigan and colleagues and published in the Journal of Thoracic Oncology, a publication of the International Association for the Study of Lung Cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel R Rygh, CRNA 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: (907) 729-2300 | Joel R Rygh, CRNA 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: (907) 729-2300 |
News Archive
Nursing students need a broader understanding of how social conditions influence the health of people living in poverty if they are to provide sensitive care, and more importantly, work toward community and policy solutions to poverty, says a new study done in part by the University of Alberta.
A series of previous studies suggested that the neuronal differentiation rate of bone marrow mesenchymal stem cells during the in vitro culture reached 78-92%, but their in vivo transplantation efficiency, and survival and differentiation rates were very low.
Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nucleotide polymorphisms. The goal is to better predict a prostate cancer's aggressiveness to avoid unnecessary radical treatment.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the release of updated financial information.
Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study from Rafael Meza from the University of Michigan and colleagues and published in the Journal of Thoracic Oncology, a publication of the International Association for the Study of Lung Cancer.
› Verified 6 days ago
Colby Parks, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: Providence Anchorage Anesthesia Medical Group, P.c., Suite 207, Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 | |
Thomas Weissmueller, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Providence Dr Ste 205, Anchorage, AK 99508 Phone: 907-561-1510 | |
Robert C Gudor, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2801 Debarr Rd, Anchorage, AK 99508 Phone: 907-258-2149 Fax: 907-258-2147 | |
Richard F Farah, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3300 Providence Dr, Suite 207, Providence Anchorage Anesthesia Medical Grou, Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 | |
Katharine Lamperti, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3300 Providence Dr., Suite 207, Providence Anchorage Anesthesia Medical Group, P.c., Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 | |
Harold W Schneider, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Mary R Lanza, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3300 Providence Dr Ste 207, Providence Anchorage Anesthesia Medical Group, P.c., Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 |